1989
DOI: 10.2307/3342801
|View full text |Cite
|
Sign up to set email alerts
|

Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae, 1963-1986

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

1989
1989
2006
2006

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 110 publications
(7 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…The objectives, methodology, and results of the randomized controlled trial in HIP has been extensively reported in the literature [1,2]. Briefly, the project was initiated in December, 1963 to determine whether periodic breast cancer screening with mammography and clinical examination of the breast holds substantial promise for lowering mortality in the female population from breast cancer.…”
Section: The Hip Studymentioning
confidence: 99%
“…The objectives, methodology, and results of the randomized controlled trial in HIP has been extensively reported in the literature [1,2]. Briefly, the project was initiated in December, 1963 to determine whether periodic breast cancer screening with mammography and clinical examination of the breast holds substantial promise for lowering mortality in the female population from breast cancer.…”
Section: The Hip Studymentioning
confidence: 99%
“…As in most countries, screening is performed as a public health activity, based on the general population, most screening trials have incorporated subjects drawn from an identifiable population by some means or other. The first screening trial was set in a contributory health plan, the Health Insurance Plan of Greater New York (HIP) 4. That made it possible to select potential trial participants from the records of the plan and invite those allocated to be screened; a comparable group was not invited but was studied as the controls.…”
Section: Selecting the Population To Studymentioning
confidence: 99%
“…However, those in the control group who would have declined to participate if they had been given the opportunity to do so cannot be identified, so the effect of screening in the group allocated to screening is diluted by the noncompliers with screening. In the HIP trial 35% declined screening,4 and in a few trials with this design the proportion of noncompliers was even higher,14 although in one of the Swedish breast screening trials more than 90% agreed to be screened 15. The other issue relates to informed consent.…”
Section: Selecting the Population To Studymentioning
confidence: 99%
See 2 more Smart Citations